With Trump's avowed interest in seeing the cost of prescriptions cut, a Democratic laser focus on the issue could actually bring about legislation to bring down drug prices. (Photo: Shutterstock)
Democratic gains in the midterms could finally bring action on drug pricing—and the pharmaceutical industry is worried.
While there's still the chance of gridlock, thanks to a still-Republican-led Senate and an intractable president, Democrats—and Representative Elijah Cummings, D-Maryland, now set to become the head of the House Oversight and Government Reform Committee—have the opportunity to flex some muscle on the issue. And that's something Cummings has already engaged in, albeit without the power behind it to make more change than noise.
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
Marlene Satter
Marlene Y. Satter has worked in and written about the financial industry for decades.
